Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation
Clinical trial NCT01203020 · COMPLETED
Trial details
- NCT number
- NCT01203020
- Sponsor
- West Virginia University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-12
- Primary completion
- 2021-09-27
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.